Revenue Growth (Constant Currency) was 8% in Q4 FY26, the quarter ended 30 Jun 2026.
| Fiscal quarter | Quarter ended | Value | Year over year |
|---|---|---|---|
| Q4 FY26 | 2026-06-30 | 8% | -11.1% |
| Q3 FY26 | 2026-03-31 | 8% | -11.1% |
| Q2 FY26 | 2025-12-31 | 9% | -10.0% |
| Q1 FY26 | 2025-09-30 | 8% | -27.3% |
| Q4 FY25 | 2025-06-30 | 9% | — |
| Q3 FY25 | 2025-03-31 | 9% | — |
| Q2 FY25 | 2024-12-31 | 10% | — |
| Q1 FY25 | 2024-09-30 | 11% | — |
Year over year is shown where the same quarter a year earlier is in the eight. Every quarter back to the first report, with CSV, is in the research platform.
Resmed reports this as “Revenue Growth (Constant Currency)” in its earnings materials. Stock Atlas keeps the company's own label and does not restate it to match other companies.
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Resmed Revenue Growth (Constant Currency) by quarter”, stockatlas.com/companies/RMD/kpi/revenue-growth-constant-currency/, data as of 3 November 2026. Links to this page are welcome.
